Plenary Session 2 Role of Rho-Kinase in the
Pathogenesis of Hypertension: Therapeutic Potential of Rho- Kinase Inhibitors
in Hypertension.
Yoshitaka Hirooka
Figure 2. The significant
decrease in systolic blood pressure and heart rate over 5-7
days was greater in the SHR than the WKY rats. The time course
of changes in blood pressure and heart rate correspond to the
time course of c-myc expression.